Evidence map›Paper›PMID 42161990›Full record

ArticleNature communications2026

Precise discrimination of G-quadruplex conformation by chiral nanoassembly with photo-reversibility.

Yongxin Chang, Yiyao Zheng, Wenwen Liu, Qianqian Qi, Miao Guo, Wenjing Sun, Yuting Xiong, Cunli Wang, Haijie Wei, Chen Li and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yongxin ChangState Key Laboratory of Medical Proteomics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, PR China.ORCID http://orcid.org/0000-0002-5473-3539
Yiyao ZhengState Key Laboratory of Medical Proteomics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, PR China.
Wenwen LiuCancer Translational Medicine Research Center, The Second Hospital, Dalian Medical University, Dalian, PR China.
Qianqian QiCollege of Chemistry and Molecular Sciences, Wuhan University, Wuhan, PR China.
Miao GuoState Key Laboratory of Medical Proteomics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, PR China.
Wenjing SunState Key Laboratory of Medical Proteomics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, PR China.
Yuting XiongState Key Laboratory of Medical Proteomics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, PR China.ORCID http://orcid.org/0000-0002-2628-4932
Cunli WangState Key Laboratory of Medical Proteomics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, PR China.
Haijie WeiState Key Laboratory of Medical Proteomics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, PR China.
Chen LiSchool of Chemistry and Molecular Engineering, East China Normal University, Shanghai, PR China.
Jiaheng ZhangCollege of Chemistry, Zhengzhou University, Zhengzhou, PR China.
Xiaoyan CuiSchool of Chemistry and Molecular Engineering, East China Normal University, Shanghai, PR China.ORCID http://orcid.org/0000-0001-6968-4701
Guoxiong WangState Key Laboratory of Catalysis, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, PR China.ORCID http://orcid.org/0000-0001-6042-1171
Shaoru WangCollege of Chemistry and Molecular Sciences, Wuhan University, Wuhan, PR China. srwang@whu.edu.cn.
Guangyan QingState Key Laboratory of Medical Proteomics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, PR China. qinggy@dicp.ac.cn.ORCID http://orcid.org/0000-0002-4888-9318

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22174138National Natural Science Foundation of China (National Science Foundation of China) 22504141
6 · The paper itself

Abstract

The precise detection and dynamic modulation of G-quadruplexes (G4s) are essential for elucidating their roles in gene regulation, genome stability, and disease pathogenesis. However, seldom has a photo-reversible small-molecule assembly capable of dynamically responding to G4s been reported. Here, we present a novel self-assembly strategy based on a π-extended compound, S2, which spontaneously forms functionalized helical nanoassemblies with a 51-fold enhanced chiral signal. These nanoassemblies enable S2 to discriminate parallel, antiparallel, and hybrid G4 topologies through ratiometric fluorescence and stereoselective spatial alignment. Remarkably, the S2 nanoassembly also exhibits enhanced sensitivity for RNA G4s over existing probes. Mechanistic studies reveal that this superior performance arises from a cascade response mechanism involving "assembly disruption-monomer release-fluorescence activation". Moreover, the photoisomerization capability of S2 facilitates reversible binding to parallel G4s under alternating UV/Vis irradiation. Finally, S2 is successfully used for in situ imaging of RNA G4s in live cells and for the detection of RNA G4s in clinical blood samples, enabling the differentiation between healthy individuals and lung cancer patients. This study introduces a "nanoassembly-G4 interactome" framework that extends beyond traditional ligand design paradigms, offering a valuable tool for the analysis of G4s in both biological and clinical contexts.

Indexed as

G-QuadruplexesNanostructuresRNAHumansLung NeoplasmsStereoisomerismRNA

Identifiers

PMID42161990
PMCPMC13402731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.